The new Corporate Communications lead is hired to "increase awareness and visibility of Xenon's emerging leadership in epilepsy" and to own corporate newsflow. But on xenon-pharma.com the "Recent news" sections on the homepage and Media page arrive only after the browser runs scripts: the HTML the server sends shows a loading spinner. The About page timeline stops at the March X-TOLE2 topline results, with no entry for the NDA submission the company announced in September, and the sitemap lists 7 pages while leaving out the Healthcare providers, Media and Therapeutic areas pages.
First action
Add the NDA submission to the About page timeline.
How to measure it
Pages listed in the sitemap
- Now
- –
- Target
- All public pages
- By
- 30 days
Steps
Agree the wording
Timeline entry from the September release.
Director/Senior Director, Corporate Communications 1 day
Review
Approve the entry and news block.
Medical, Legal and Regulatory review 2 days
Server-render news
Latest five releases in the HTML.
Digital and web team 3 days
Rebuild the sitemap
From routes, with real dates.
Digital and web team 1 day
Share images
Default image and full descriptions.
Digital and web team 1 day
Check previews
LinkedIn, X and email previews of key pages.
Director/Senior Director, Corporate Communications 1 hour
Keep current
Add each milestone the day it is announced.
Director/Senior Director, Corporate Communications ongoing
Why it works
Render the latest five press releases into the homepage and Media page HTML on the server (title, date, link to the investor site), add the September NDA submission to the About timeline in the company's own approved wording, and generate the sitemap from the site's routes so every public page is listed with its real update date. Add a default share image and complete the cut-off share descriptions at the same time.
Journalists, analysts, prospective hires and HCPs often meet Xenon through a link preview, a search result or an AI assistant's summary. Each of those reads the server HTML and the sitemap, so the company's biggest milestone should be in both.
Ready to use
ChecklistNewsflow on the corporate site
[ ] Latest press releases in server HTML on / and /media [ ] NDA submission on the About timeline (approved wording) [ ] Sitemap includes /health-care-providers, /media, /pipeline/therapeutic-areas, /contact-us [ ] Real lastmod dates per page [ ] Default og:image and full og:description on every page [ ] Open positions rendered in server HTML on /join-us [ ] Milestone checklist added to the release-day runbook
Risks and how to handle them
Wording about regulatory status
Reuse only the approved press release language.
Two sites drift apart
Pull news from the investor site feed rather than copying by hand.
Evidence
- HiringDirector/Senior Director, Corporate Communications (Needham, MA, posted September 8, 2026): "Increase awareness and visibility of Xenon's emerging leadership in epilepsy, including forthcoming potential launch of azetukalner in focal seizures and our emergence as a leading biopharma company soon to be a fully integrated commercial organization"; owns "corporate newsflow, including business updates, clinical trial milestones, data readouts and future product launches" for "investors and media, healthcare professionals, and the patient community".Source
- Your websiteHomepage and Media page (checked twice on October 23, 2026): the "Recent news" section is filled in by the browser; the HTML the server sends shows only a loading spinner, so link previews, many crawlers and AI assistants see no news on xenon-pharma.com. The Join Us page's open positions likewise say "Loading open positions...". Press releases live on investor.xenon-pharma.com.Source
- Your websiteAbout page milestone timeline: the newest entry is "Announced positive topline results from Phase 3 X-TOLE2 study of azetukalner in focal onset seizures"; the September NDA submission is not listed.Source
- Your websiteSitemap (checked October 23, 2026): 7 URLs, all with the same lastmod; it omits linked pages such as /health-care-providers, /media, /pipeline/therapeutic-areas and /contact-us. The homepage has no social share image, and the Patients page's share description is cut off at "Patient collaboration drives the".Source
- HiringCompany description in every job post: "In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we submitted a New Drug Application to the Food and Drug Administration in the third quarter of 2026"; X-TOLE3 "would support regulatory submissions outside the U.S."; X-ACKT is in primary generalized tonic-clonic seizures. The Ashby board lists 25 open roles across Boston, Vancouver and U.S. field territories, including CMC and quality roles for "Late Stage/Commercial" manufacturing.Source